These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38375187)

  • 21. Prevalence, associated factors and rifampicin resistance pattern of pulmonary tuberculosis among HIV-positive patients attending antiretroviral treatment clinic at East Gojjam Zone, Ethiopia: An institution-based cross-sectional study.
    Toru M; Baye A; Gebeyehu Z; Abebaw A; Reta A
    J Clin Tuberc Other Mycobact Dis; 2022 Dec; 29():100336. PubMed ID: 36405997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency of Pulmonary Hypertension and Its Associated Risk Factors in End-Stage Renal Disease (ESRD) Patients on Maintenance Hemodialysis.
    Khemchandani M; Nasir K; Qureshi R; Dhrolia M; Ahmad A
    Cureus; 2024 Feb; 16(2):e55206. PubMed ID: 38558648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of Dialysis Among Patients With End-Stage Renal Disease (ESRD).
    Ejaz A; Junejo AM; Ali M; Ashfaq A; Hafeez AR; Khan SA
    Cureus; 2021 Aug; 13(8):e17006. PubMed ID: 34540407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health-related quality of life among patients with end-stage renal disease undergoing hemodialysis in Ethiopia: a cross-sectional survey.
    Gebrie MH; Asfaw HM; Bilchut WH; Lindgren H; Wettergren L
    Health Qual Life Outcomes; 2023 Apr; 21(1):36. PubMed ID: 37069562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multifactorial analysis of renal anemia-associated substandard hemoglobin levels and prevalence of anemia in patients on maintenance hemodialysis in Liaoning Province: a cross-sectional study.
    Yin S; Du Y; Guo Y; Guo G; Sun D; Yao L
    Ann Palliat Med; 2022 Dec; 11(12):3743-3754. PubMed ID: 36635999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. End-stage Renal Disease and Risk of Active Tuberculosis: a Nationwide Population-Based Cohort Study.
    Min J; Kwon SK; Jeong HW; Han JH; Kim YJ; Kang M; Kang G
    J Korean Med Sci; 2018 Dec; 33(53):e341. PubMed ID: 30595682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Undernutrition and Mortality among Adult Tuberculosis Patients in Addis Ababa, Ethiopia.
    Seid G; Ayele M
    Adv Prev Med; 2020; 2020():5238010. PubMed ID: 32802521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan.
    Bukhari H; Ahmad A; Noorin A; Khan A; Mushtaq M; Naeem A; Iqbal MR; Naureen F; Shah Y; Qayyum A; Munib S; Azhar A; Ullah F; Khan FFS
    Int J Clin Pract; 2023; 2023():7418857. PubMed ID: 36815007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mortality and associated risk factors in a cohort of tuberculosis patients treated under DOTS programme in Addis Ababa, Ethiopia.
    Getahun B; Ameni G; Biadgilign S; Medhin G
    BMC Infect Dis; 2011 May; 11():127. PubMed ID: 21575187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eleven years of experience with dialysis associated tuberculosis.
    Malik GH; Al-Harbi AS; Al-Mohaya S; Al-Khawajah H; Kechrid M; Al Hassan AO; Balbaid K; Shetia MS
    Clin Nephrol; 2002 Nov; 58(5):356-62. PubMed ID: 12425486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Active tuberculosis in patients undergoing hemodialysis for end-stage renal disease: a 9-year retrospective analysis in a single center.
    Nakamura H; Tateyama M; Tasato D; Teruya H; Chibana K; Tamaki Y; Haranaga S; Yara S; Higa F; Fujita J
    Intern Med; 2009; 48(24):2061-7. PubMed ID: 20009393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment outcomes of childhood tuberculosis in Addis Ababa: a five-year retrospective analysis.
    Tilahun G; Gebre-Selassie S
    BMC Public Health; 2016 Jul; 16():612. PubMed ID: 27443308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the Prevalence of Latent Tuberculosis Infection among Non-Dialysis Patients with Severe Chronic Kidney Disease, Patients Receiving Dialysis, and the Dialysis-Unit Staff: A Cross-Sectional Study.
    Shu CC; Hsu CL; Lee CY; Wang JY; Wu VC; Yang FJ; Wang JT; Yu CJ; Lee LN
    PLoS One; 2015; 10(4):e0124104. PubMed ID: 25919813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and Epidemiological Profiles of Patients with End Stage Kidney Disease on Dialysis at Dialysis Centers in Addis Ababa, Ethiopia.
    Seifu L; Getachew S; Abebe B; Debay Z
    Ethiop J Health Sci; 2023 May; 33(3):499-506. PubMed ID: 37576172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of stock-outs of first line anti-tuberculosis drugs: the case of public health facilities of Addis Ababa city administration health bureau, Addis Ababa, Ethiopia.
    Sintayehu K; Zeleke ED; Temesgen B; Kifle M; Assefa DG; Zenebe K; Kassahun A; Yimer BT
    BMC Health Serv Res; 2022 Aug; 22(1):1047. PubMed ID: 35978406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tuberculosis care strategies and their economic consequences for patients: the missing link to end tuberculosis.
    Getahun B; Wubie M; Dejenu G; Manyazewal T
    Infect Dis Poverty; 2016 Nov; 5(1):93. PubMed ID: 27799063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-Time Impact of COVID-19 on Clinical Care and Treatment of Patients with Tuberculosis: A Multicenter Cross-Sectional Study in Addis Ababa, Ethiopia.
    Chilot D; Woldeamanuel Y; Manyazewal T
    Ann Glob Health; 2021; 87(1):109. PubMed ID: 34824990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-gamma release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients.
    Winthrop KL; Nyendak M; Calvet H; Oh P; Lo M; Swarbrick G; Johnson C; Lewinsohn DA; Lewinsohn DM; Mazurek GH
    Clin J Am Soc Nephrol; 2008 Sep; 3(5):1357-63. PubMed ID: 18550653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Underlying Comorbidities and Sites of tuberculosis: an analysis using surveillance data.
    Jeong YJ; Kang JY; Kim HW; Min J; Ko Y; Oh JY; Kang HH; Lim SC; Hwang HG; Shin KC; Lee HB; Kim JS; Park JS; Lee SS; Koo HK
    BMC Pulm Med; 2022 Nov; 22(1):417. PubMed ID: 36371212
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.